- #102 Kiran Mazumdar-Shaw ₹32,900 Cr

About Biocon Research Limited
Data last updated:
Biocon Research Limited is a public limited company based in Bangalore, Karnataka, India, a subsidiary of Biocon Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 28 May 2008 and has been in existence for over 18 years.
Its director Kiran Mazumdar-Shaw is #102 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2008PLC046583. The company has 3 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Kiran Mazumdar Shaw and John Mccallum Marshall Shaw.
Its last annual general meeting (AGM) was held on 26 July 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 20th Km Hosur Road Electronics City P.O., Bangalore, Karnataka, India – 560100.
As per the financials filed for FY 2019, the company reported a revenue of ₹247 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹55.7 Cr (net margin 22.6%) and EBITDA of ₹90.9 Cr (EBITDA margin 36.8%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years.
The company has about 517 employees on its provident fund (EPFO) records.
Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biocon.com.
Company details
Recognitions & Rankings of Biocon Research
Contact details
Biocon Research Limited's registered office is in Bangalore, Karnataka. Its website is biocon.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address20th Km Hosur Road Electronics City P.O., Bangalore, Karnataka, India – 560100
- IndustryLife Sciences, Biotechnology
To see the full contact details of Biocon Research Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biocon Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Biocon Research Limited, buy the company report.
Financials of Biocon Research Limited
FY 2019 filings availableBiocon Research Limited reported revenue of ₹247 Cr (up 13% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 13% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 16%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹247 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹90.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹55.7 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 36.8% | ||||
| Net Profit Margin | 22.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biocon Research Limited, buy the company report.
Board of directors of Biocon Research Limited
Biocon Research has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Mazumdar Shaw | Director | 28 May 2008 | 18 Years 5 Months | Current |
| John Mccallum Marshall Shaw | Director | 28 May 2008 | 18 Years 5 Months | Current |
| Arun Suresh Chandavarkar | Director | 28 May 2008 | 18 Years 5 Months | Current |
Auditor
Biocon Research Limited is audited by B S R & Co. LLP for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co. LLP | FY 2019 | 101248W/W100022 |
Shareholding
The shareholding of Biocon Research Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biocon Research Limited, buy the company report.
Legal cases
Biocon Research Limited has 2 court cases on record: 2 filed by Biocon Research. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against The Additional Commissioner of Income Tax | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against The Additional Commissioner | Disposed |
To see the full case history of Biocon Research Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biocon Research Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Biocon Research Limited has a workforce of 517 employees on its EPFO records as of Mar 2020, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2019-20 | 517 |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Biocon Research Limited, buy the company report.
GST
Biocon Research has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Biocon Research Limited, buy the company report.
Recent activity
Biocon Research Limited has 6 board changes on record since 2008: 3 appointments and 3 cessations. The latest: Daniel Mark Bradbury ceased to be Director on 26 Oct 2017.
News
Frequently asked questions
Biocon Research is an active public limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 28 May 2008 (18+ years old) and is registered under CIN U73100KA2008PLC046583.
Biocon Research has 3 current directors:
- Kiran Mazumdar Shaw - Director
- John Mccallum Marshall Shaw - Director
- Arun Suresh Chandavarkar - Director
The latest financial statements of Biocon Research on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 26 July 2019. Year-wise statements from 2015 are in the company report.
No. Biocon Research has 3 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Biocon Research is U73100KA2008PLC046583. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biocon Research has 2 court cases on record: 2 filed by the company.
Biocon Research was incorporated on 28 May 2008, making it 18+ years old. It is registered with the Registrar of Companies, Bangalore.
Daniel Mark Bradbury ceased to be Director on 26 Oct 2017. John Russell Fotheringham Walls ceased to be Director on 26 Oct 2017. Harish Venkatachalam Iyer ceased to be Director on 23 May 2011. Biocon Research has 6 board changes on record in total.
Biocon Research can be reached through the website biocon.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Biocon Research is at 20th Km Hosur Road Electronics City P.O., Bangalore, Karnataka, India – 560100.

